Advance notification that the Ministry of Health will soon be considering the following drugs for PharmaCare coverage

Advance notification that the Ministry of Health will soon be considering the following drugs for PharmaCare coverage:

Generic name: vanzacaftor, tezacaftor, deutivacaftor

Brand name: Alyftrek™

Drug used for: The treatment of cystic fibrosis (CF) in people aged 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene

Tentative Dates for Input: From Wednesday, August 27, 2025, to Tuesday, September 23, 2025,

AT 11:59 PM

Generic name: delgocitinib

Brand name: TBC (to be confirmed)

Drug used for: For the treatment of moderate to severe chronic hand eczema (CHE), including the relief of pain and pruritus (itching), in adults

Tentative Dates for Input: From Wednesday, August 27, 2025, to Tuesday, September 23, 2025,

AT 11:59 PM

You will receive an additional notification once the drugs are available for input.

Once the drugs are available for input, you can provide input by visiting our website at http://www.gov.bc.ca/bcyourvoice.